Senior insider sale
EVP & Co-Head Research & Inv. at ROYALTY PHARMA PLC — senior position signals high conviction
$2.70M
49.69K shares
What this filing means
URIST MARSHALL plans to sell 49.69K shares of ROYALTY PHARMA PLC valued at approximately $2.70M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/28/2026ACC: 0001964306-26-000456
Officer· EVP & Co-Head Research & Inv.
Since Dec 2020
49.69K
Shares to sell
$2.70M
Approx. market value
4.13K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Equity Performance Award
Granted as part of issuer equity compensation program
8/5/2026
4.13KTotal acquired4.13K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/5/2026 | Equity Performance Award Granted as part of issuer equity compensation program | 4.13K | — |
| Total | 4.13K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
9.10K
Market value
$508.5K
7/1/2026
—Completed
Units to sell
9.10K
Market value
$502.1K
6/24/2026
—Completed
Units to sell
13.68K
Market value
$721.8K
5/20/2026
—Completed
Units to sell
13.68K
Market value
$726.1K
5/14/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.13K
Market value
$238.8K
9/28/2026
Total
Units
49.69K
Value
$2.70M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/1/2026 | 9.10K | $508.5K | — | Completed |
6/24/2026 | 9.10K | $502.1K | — | Completed |
5/20/2026 | 13.68K | $721.8K | — | Completed |
5/14/2026 | 13.68K | $726.1K | — | Completed |
| Planned — Approximate Date | ||||
9/28/2026 | 4.13K | $238.8K | NASDAQ | Planned |
| Total | 49.69K | $2.70M | ||